A body of research has demonstrated that ER-β and its isoforms, in conjunction with co-regulators such as AIB1, NF-κB, and TIF-2, have a tendency to co-regulate the proliferation and progression of breast cancer cells (48). The gene discussed is ESR2; the disease is breast carcinoma.